|
Selvi Thirumurthi describes for SIIC the most significant aspects of his article describe para SIIC los aspectos relevantes de su artículo Review of the clinical consequences of H. pylori infection, rationale for country-wide eradication, resistance patterns and treatment strategies for developing countries. HELICOBACTER PYLORI INFECTION IN INDIA FROM A WESTERN PERSPECTIVE Helicobacter pylori is an important human pathogen. Physicians in developing countries face several challenges in both diagnosis and treatment including costs, availability, treatment success rates and increased recurrence after therapy. We review the clinical consequences of infection, rationale for eradication, resistance patterns and treatment strategies in India. The article was published by El artículo fue publicado por
Principal institution where the research took place Institución principal de la investigación Baylor College of Medicine, Michael E. DeBakey VA Medical Center, Houston, Texas, United States  Authors' Report Crónica del Autor Infección por Helicobacter pylori en la India desde la Perspectiva Occidental Helicobacter pylori es un importante patógeno para los seres humanos. Los profesionales de los países en vías de desarrollo enfrentan numerosos desafíos diagnósticos y terapéuticos, en términos de los costos, la disponibilidad, los índices de tratamiento exitoso y la posible recurrencia luego de la terapia. Se revisan las consecuencias de la infección, los motivos para la erradicación, los patrones de resistencia y las estrategias terapéuticas en la India. Crónica del Autor Imprimir nota Referencias bibliográficas Abraham P, Bhatia SJ. Position paper on Helicobacter pylori in India. Indian Society of Gastroenterology. Indian J Gastroenterol 16(Suppl 1):S29-33, 1997. Ahmed KS, Khan AA, Ahmed I, Tiwari SK, Habeeb A, Ahi JD, et al. Impact of household hygiene and water source on the prevalence and transmission of Helicobacter pylori: a South Indian perspective. Singapore Med J 48:543-9, 2007. Atherton JC, Blaser MJ. Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J Clin Invest 119:2475-87, 2009. Bhatia SJ, Kulkarni SG. Cost-effectiveness of Helicobacter pylori eradication in India: to live and let live... expensively? Indian J Gastroenterol 16(Suppl 1):S25-8, 1997. Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol 7:887-94, 2009. Cardenas VM, Ortiz M, Graham DY. Helicobacter pylori eradication and its effect on iron stores: A reappraisal. J Infect Dis 194:714, 2006. Chowdhury A, Berg DE, Jeong JY, Mukhopadhyay AK, Nair GB. Metronidazole resistance in Helicobacter pylori: magnitude, mechanism and implications for India. Indian J Gastroenterol 21:23-8, 2002. Correa P, Cuello C, Fajardo LF, Haenszel W, Bolanos O, De Ramirez B. Diet and gastric cancer: nutrition survey in a high- risk area. J Natl Cancer Inst 70:673-8, 1983. Devarbhavi H, Nanivadekar S, Sawant P, Saraswathy K. Sensitivity of Helicobacter pylori isolates from Indian patients to different antibacterial agents. Indian J Gastroenterol 17(Suppl 1):S53, 1998. Dewan R, Sachdev GK. Diagnosis of Helicobacter pylori infection in primary and tertiary care centers. Indian J Gastroenterol 19(Suppl 1):S11-4, 2000. Dikshit RP, Mathur G, Mhatre S, Yeole BB. Epidemiological review of gastric cancer in India. Indian J Med Paediatr Oncol 32:3-11, 2011. Eapen CE. Recurrence of Helicobacter pylori infection after eradication. Indian J Gastroenterol 19(Suppl 1):S25-7, 2000. Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 59:1143-53, 2010. Graham DY, Lu H, Yamaoka Y. A report card to grade Helicobacter pylori therapy. Helicobacter 12:275-8, 2007. Graham DY, Yamaoka Y, Malaty HM. Contemplating the future without Helicobacter pylori and the dire consequences hypothesis. Helicobacter 12(Suppl 2):64-8, 2007. Graham DY. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology 113:1983-91, 1997. Hwang H, Dwyer J, Russell RM. Diet, Helicobacter pylori infection, food preservation and gastric cancer risk: are there new roles for preventative factors? Nutr Rev 52:75-83, 1994. Nurgalieva ZZ, Malaty HM, Graham DY, Almuchambetova R, Machmudova A, Kapsultanova D, et al. Helicobacter pylori infection in Kazakhstan: effect of water source and household hygiene. Am J Trop Med Hyg 67:201-6, 2002. Raj SM, Choo KE, Noorizan AM, Lee YY, Graham DY. Evidence against Helicobacter pylori being related to childhood asthma. J Infect Dis 199:914-5, 2009. Rimbara E, Fischbach LA, Graham DY. Optimal therapy for Helicobacter pylori infections. Nat Rev Gastroenterol Hepatol 8:79-88, 2008. Singh V, Trikha B, Nain CK, Singh K, Vaiphei K. Epidemiology of Helicobacter pylori and peptic ulcer in India. J Gastroenterol Hepatol 17:659-65, 2002. Thirumurthi S, Graham DY. Helicobacter pylori infection in India from a western perspective. Indian J Med Res 136:549-562, 2012. Thomson CA, LeWinn K, Newton TR, Alberts DS, Martinez ME. Nutrition and diet in the development of gastrointestinal cancer. Curr Oncol Rep 5:192-202, 2003. Walker SP, Wachs TD, Gardner JM, Lozoff B, Wasserman GA, Pollitt E, et al. Child development: risk factors for adverse outcomes in developing countries. Lancet 369:145-57, 2007. Other articles written by the author Selvi Thirumurthi Otros artículos de Selvi Thirumurthi Attumi TA, Graham DY. Increasing the duration of dual amoxicillin plus omeprazole Helicobacter pylori eradication to 6 weeks: a pilot study. J Gastroenterol Hepatol 27:59-61, 2012. Graham DY, Lu H. Furazolidone in Helicobacter pylori therapy: Misunderstood and often unfairly maligned drug told in a story of French bread. Saudi J Gastroenterol 18:1-2, 2012. Graham DY, Calvet X. Guide regarding choice of second-line therapy to obtain a high cumulative cure rate. Helicobacter 17:243-245, 2012. Graham DY, Shiotani A. Which therapy for Helicobacter pylori infection? Gastroenterology 143:10-12, 2012. Lee YY, Ismail AW, Mustaffa N, Musa KI, Majid NA, Choo KE, Mahendra RS, Derakhshan MH, Malaty HM, Graham DY. Sociocultural and dietary practices among Malay subjects in the North-Eastern region of peninsular Malaysia: A region of low prevalence of Helicobacter pylori infection. Helicobacter 17:54-61, 2012. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ. Management of Helicobacter pylori infection--the Maastricht IV/Florence Consensus Report. Gut 61:646-664, 2012. Dore MP, Farina V, Cuccu M, Mameli L, Massarelli G, Graham DY. Twice-a-day bismuth-containing quadruple therapy for Helicobacter pylori eradication: a randomized trial of 10 and 14 days. Helicobacter 16:295-300, 2011. Graham DY, Fischbach LA. Empiric therapies for Helicobacter pylori infections. CMAJ, 2011. Graham DY, Dore MP. Helicobacter pylori therapy demystified. Helicobacter 16:343-345, 2011. Rimbara E, Fischbach LA, Graham DY. Optimal therapy for Helicobacter pylori infections. Nat Rev Gastroenterol Hepatol 8:79-88, 2011. SIIC System of Assisted Editing (SSEA) / Sistema SIIC de Edición Asistida (SSEA)
The article is strictly related to the following sections of siicsalud El artículo se relaciona estrictamente con las siguientes secciones de siicsalud
Information about the full text Acerca del trabajo completo Helicobacter Pylori Infection in India From a Western Perspective Author / Autor Selvi Thirumurthi1, David Y. Graham2 2 Md, Baylor College Of Medicine, Michael E. Debakey Va Medical Center, Professor Of Medicine, Molecular Virolog Access to the original source Indian Journal of Medical Research (IJMR) siic DB: / siic DB: http://www.siicsalud.com/main/distriprinrel.php |
|||||||||||||||||||||||
Copyright siicsalud © 1997-2024 ISSN siicsalud: 1667-9008
